CDKN1A and viral infectious disease: Additional proviral hits CDKN1A (p21) and TNFRSF10A, ISGs with antiproliferative and/or proapoptotic effects [65,66], were depleted upon Dox treatment independently of viral infection, and were further depleted by SARS-CoV-2 infection.